Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

What are the benefits of medical screening and surveillance?

Dennis Wilken, Xaver Baur, Lioubov Barbinova, Alexandra Preisser, Evert Meijer, Jos Rooyackers, Dick Heederik on behalf of the ERS Task Force on the Management of Work-related Asthma
European Respiratory Review 2012 21: 105-111; DOI: 10.1183/09059180.00005011
Dennis Wilken
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xaver Baur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: baur@uke.de
Lioubov Barbinova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Preisser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evert Meijer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jos Rooyackers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dick Heederik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Flow chart for medical surveillance to detect work-related asthma (WRA) due to aero-allergens. P(S+): probability of sensitisation assessed by a regular questionnaire; HS: high score, i.e. high probability; IS: intermediate score, i.e. intermediate probability. Adapted from [54] with permission from the publisher.

Tables

  • Figures
  • Table 1. Recommendations
    RecommendationsStrength of recommendationLevel of evidence
    Questionnaire-based identification of all workers at risk of developing work-related asthma is recommended as basis for surveillanceStrongHigh
    Pre-placement screening for specific cross-reacting, work-associated sensitisation among potentially HMW allergen-exposed subjects is recommended in order to identify those at higher risk for work-related asthmaStrongModerate
    Detection of sensitisation either by specific IgE or SPT should be included in surveillance (not only pre-placement) for identification of subjects at risk of work-related asthma with foreseeable regular exposure to HMW agents (such as laboratory animals, bakery dust, enzymes or latex)StrongModerate
    In atopics and subjects with pre-existing asthma or sensitisation, pre-employment investigation should be performed in order to inform them about their increased work-related asthma risk
    Because of the low PPV, exclusion of asymptomatic atopics or sensitised subjects from exposure to potential occupational allergens or irritant agents cannot be recommended
    WeakModerate
    In all workers with confirmed occupational rhinitis and/or NSBHR, medical surveillance programmes should be performed
    They should include periodic administration of a questionnaire, detection of sensitisation by standardised SPT or serum specific IgE antibodies, early referral of symptomatic and/or sensitised subjects for specialised medical assessment and assessment of asthma Surveillance programmes should already be implemented during vocational training of individuals at risk
    StrongModerate
    Identification of symptoms or sensitisation during surveillance should result in an investigation to confirm or exclude occupational asthma, work-related asthma, rhinitis and COPDStrongHigh
    Risk stratification by diagnostic models can be used in medical surveillance to select exposed workers for further medical evaluationStrongModerate
    As a secondary prevention measure, a comprehensive medical surveillance programme should, in addition to early detection of sensitisation, allergic symptoms and occupational asthma, comprise exposure assessment and intervention targeted both at workers and exposureStrongModerate
    • HMW: high molecular weight; Ig: immunoglobulin; SPT: skin-prick test; PPV: positive predictive value; NSBHR: nonspecific bronchial hyperresponsiveness; COPD: chronic obstructive pulmonary disease.

PreviousNext
Back to top
View this article with LENS
Vol 21 Issue 124 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
What are the benefits of medical screening and surveillance?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
What are the benefits of medical screening and surveillance?
Dennis Wilken, Xaver Baur, Lioubov Barbinova, Alexandra Preisser, Evert Meijer, Jos Rooyackers, Dick Heederik
European Respiratory Review Jun 2012, 21 (124) 105-111; DOI: 10.1183/09059180.00005011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
What are the benefits of medical screening and surveillance?
Dennis Wilken, Xaver Baur, Lioubov Barbinova, Alexandra Preisser, Evert Meijer, Jos Rooyackers, Dick Heederik
European Respiratory Review Jun 2012, 21 (124) 105-111; DOI: 10.1183/09059180.00005011
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Epidemiology, occupational and environmental lung disease
  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2022 by the European Respiratory Society